J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 581, Number 1, 107-128, May 15, 2007 DOI: 10.1113/jphysiol.2006.124958
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
581/1/107    most recent
jphysiol.2006.124958v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dravid, S. M.
Right arrow Articles by Traynelis, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dravid, S. M.
Right arrow Articles by Traynelis, S. F.
Related Collections
Right arrow Neuroscience
Right arrowRelated Article

NEUROSCIENCE

Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block

Shashank M. Dravid1, Kevin Erreger2, Hongjie Yuan1, Katherine Nicholson3, Phuong Le1, Polina Lyuboslavsky1, Antoine Almonte1, Ernest Murray4, Cara Mosley4, Jeremy Barber1, Adam French1, Robert Balster5, Thomas F. Murray6 and Stephen F. Traynelis1

1 Departments of Pharmacology and
4 Chemistry, Emory University, Atlanta, GA 30322, USA
2 Department of Molecular Physiology and Biophysics, Vanderbilt University, 465 21st Avenue S, MRB III Room 7124, Nashville, TN 37232, USA
3 Department of Pharmacology and Toxicology and
5 Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA 23298, USA
6 Department of Pharmacology, Creighton University, 2500 California Plaza, Omaha, NE 68178, USA

We have compared the potencies of structurally distinct channel blockers at recombinant NR1/NR2A, NR1/NR2B, NR1/NR2C and NR1/NR2D receptors. The IC50 values varied with stereochemistry and subunit composition, suggesting that it may be possible to design subunit-selective channel blockers. For dizocilpine (MK-801), the differential potency of MK-801 stereoisomers determined at recombinant NMDA receptors was confirmed at native receptors in vitro and in vivo. Since the proton sensor is tightly linked both structurally and functionally to channel gating, we examined whether blocking molecules that interact in the channel pore with the gating machinery can differentially sense protonation of the receptor. Blockers capable of remaining trapped in the pore during agonist unbinding showed the strongest dependence on extracellular pH, appearing more potent at acidic pH values that promote channel closure. Determination of pKa values for channel blockers suggests that the ionization of ketamine but not of other blockers can influence its pH-dependent potency. Kinetic modelling and single channel studies suggest that the pH-dependent block of NR1/NR2A by (–)MK-801 but not (+)MK-801 reflects an increase in the MK-801 association rate even though protons reduce channel open probability and thus MK-801 access to its binding site. Allosteric modulators that alter pH sensitivity alter the potency of MK-801, supporting the interpretation that the pH sensitivity of MK-801 binding reflects the changes at the proton sensor rather than a secondary effect of pH. These data suggest a tight coupling between the proton sensor and the ion channel gate as well as unique subunit-specific mechanisms of channel block.

(Received 14 November 2006; accepted after revision 8 February 2007; first published online 15 February 2007)
Corresponding author S. Dravid: Department of Pharmacology, Emory University School of Medicine, Rollins Research Centre, 1510 Clifton Road, Atlanta, GA 30322-3090, USA. Email: smdravid{at}pharm.emory.edu


Related Article

NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies
Georg Köhr
J. Physiol. 2007 581: 1-2. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Physiol.Home page
S. M. Dravid, A. Prakash, and S. F. Traynelis
Activation of recombinant NR1/NR2C NMDA receptors
J. Physiol., September 15, 2008; 586(18): 4425 - 4439.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Xia, C. Z. Wang, J. Liu, N. C. Anastasio, and K. M. Johnson
Lithium Protection of Phencyclidine-Induced Neurotoxicity in Developing Brain: The Role of Phosphatidylinositol-3 Kinase/Akt and Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Signaling Pathways
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 838 - 848.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Hevers, S. H. Hadley, H. Luddens, and J. Amin
Ketamine, But Not Phencyclidine, Selectively Modulates Cerebellar GABAA Receptors Containing {alpha}6 and {delta} Subunits
J. Neurosci., May 14, 2008; 28(20): 5383 - 5393.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H.-R. Chang and C.-C. Kuo
The Activation Gate and Gating Mechanism of the NMDA Receptor
J. Neurosci., February 13, 2008; 28(7): 1546 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. C. Wrighton, E. J. Baker, P. E. Chen, and D. J. A. Wyllie
Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes
J. Physiol., January 1, 2008; 586(1): 211 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Kohr
NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies
J. Physiol., May 15, 2007; 581(1): 1 - 2.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 The Physiological Society.